Cargando…
Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors
It is of interest to elucidate the binding mode analysis of 18 sulphonated flavones in the non nucleoside inhibitory binding pocket of the HIV-1 reverse transcriptase (PDB ID: 1RTD). We further compared them with the known Non Nucleosidic Reverse Transcriptase Inhibitors (NNRTI) drug molecules such...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859701/ https://www.ncbi.nlm.nih.gov/pubmed/31787814 http://dx.doi.org/10.6026/97320630015646 |
_version_ | 1783471170006286336 |
---|---|
author | Alaoui, My Abdelaziz El Fartah, Souad El Alaoui, Najwa Fahime, El Mostapha El Habsaoui, Amar |
author_facet | Alaoui, My Abdelaziz El Fartah, Souad El Alaoui, Najwa Fahime, El Mostapha El Habsaoui, Amar |
author_sort | Alaoui, My Abdelaziz El |
collection | PubMed |
description | It is of interest to elucidate the binding mode analysis of 18 sulphonated flavones in the non nucleoside inhibitory binding pocket of the HIV-1 reverse transcriptase (PDB ID: 1RTD). We further compared them with the known Non Nucleosidic Reverse Transcriptase Inhibitors (NNRTI) drug molecules such as delaviridine, nevirapine and etravirine. Molecular docking studies of sulphonated flavones were performed in the binding pocket of reverse transcriptase using the PatchDock server. The flavones have different binding energies with RT and the atomic contact energy (ACE) value of sulfonated flavones range from-389 to-231 Kcal/mol while docking of the commercialized NNRTI showed the ACE value range from -486 to -224 Kcal/mol. This shows that most sulfonated flavones have ACE similar to the known NNRTI. Thus, seven compounds (FS-6, FS-7, FS-8, FS-9, FS-14, FS-15, FS-17) were reported as potent, selective, orally bio available, and nontoxic lead based on ADMET screening and effective binding analysis in the active site of the reverse transcriptase (PDB ID: 1RTD) for further consideration. We further document that compounds (FS-1, FS-10, FS-4 and FS-12) have unfavorable binding features to be considered as leads. |
format | Online Article Text |
id | pubmed-6859701 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Biomedical Informatics |
record_format | MEDLINE/PubMed |
spelling | pubmed-68597012019-11-29 Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors Alaoui, My Abdelaziz El Fartah, Souad El Alaoui, Najwa Fahime, El Mostapha El Habsaoui, Amar Bioinformation Research Article It is of interest to elucidate the binding mode analysis of 18 sulphonated flavones in the non nucleoside inhibitory binding pocket of the HIV-1 reverse transcriptase (PDB ID: 1RTD). We further compared them with the known Non Nucleosidic Reverse Transcriptase Inhibitors (NNRTI) drug molecules such as delaviridine, nevirapine and etravirine. Molecular docking studies of sulphonated flavones were performed in the binding pocket of reverse transcriptase using the PatchDock server. The flavones have different binding energies with RT and the atomic contact energy (ACE) value of sulfonated flavones range from-389 to-231 Kcal/mol while docking of the commercialized NNRTI showed the ACE value range from -486 to -224 Kcal/mol. This shows that most sulfonated flavones have ACE similar to the known NNRTI. Thus, seven compounds (FS-6, FS-7, FS-8, FS-9, FS-14, FS-15, FS-17) were reported as potent, selective, orally bio available, and nontoxic lead based on ADMET screening and effective binding analysis in the active site of the reverse transcriptase (PDB ID: 1RTD) for further consideration. We further document that compounds (FS-1, FS-10, FS-4 and FS-12) have unfavorable binding features to be considered as leads. Biomedical Informatics 2019-10-12 /pmc/articles/PMC6859701/ /pubmed/31787814 http://dx.doi.org/10.6026/97320630015646 Text en © 2019 Biomedical Informatics http://creativecommons.org/licenses/by/3.0/ This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License. |
spellingShingle | Research Article Alaoui, My Abdelaziz El Fartah, Souad El Alaoui, Najwa Fahime, El Mostapha El Habsaoui, Amar Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors |
title | Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors |
title_full | Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors |
title_fullStr | Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors |
title_full_unstemmed | Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors |
title_short | Molecular docking analysis of flavonoid compounds with HIV-1 Reverse transcriptase for the identification of potential effective inhibitors |
title_sort | molecular docking analysis of flavonoid compounds with hiv-1 reverse transcriptase for the identification of potential effective inhibitors |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6859701/ https://www.ncbi.nlm.nih.gov/pubmed/31787814 http://dx.doi.org/10.6026/97320630015646 |
work_keys_str_mv | AT alaouimyabdelazizel moleculardockinganalysisofflavonoidcompoundswithhiv1reversetranscriptasefortheidentificationofpotentialeffectiveinhibitors AT fartahsouadel moleculardockinganalysisofflavonoidcompoundswithhiv1reversetranscriptasefortheidentificationofpotentialeffectiveinhibitors AT alaouinajwa moleculardockinganalysisofflavonoidcompoundswithhiv1reversetranscriptasefortheidentificationofpotentialeffectiveinhibitors AT fahimeelmostaphael moleculardockinganalysisofflavonoidcompoundswithhiv1reversetranscriptasefortheidentificationofpotentialeffectiveinhibitors AT habsaouiamar moleculardockinganalysisofflavonoidcompoundswithhiv1reversetranscriptasefortheidentificationofpotentialeffectiveinhibitors |